Posters
OMNI 360™ in open-angle glaucoma treatment: a 6 month follow-up
Poster Details
First Author: I.Grabska - Liberek POLAND
Co Author(s): J. Majszyk - Ionescu A. Skowyra M. Rogowska A. Plichta P. Duda I. Kane
Abstract Details
Purpose:
To analyze the safety and efficacy of the OMNI TM surgical procedure in reducing intraocular pressure (IOP) and the number of glaucoma medications in adult subjects with open-angle glaucoma (OAG).
Setting:
Department of Ophthalmology, Medical Center of Postgraduate Education, Warsaw, Poland
Methods:
In a single-surgeon prospective clinical study, 10 eyes of 9 OAG patients underwent OMNI TM surgery. Four eyes of 3 patients underwent OMNI TM alone, and 6 eyes of 6 patients underwent OMNI TM combined with cataract surgery. All patients will have been followed-up for 6 months at the time of presentation. Changes in intraocular pressure (IOP), intraoperative, and postoperative complications will be examined and recorded. Success is defined as post-operative IOP reduction ≥ 20%, from a baseline without glaucoma medications ("complete success") or with topical treatment ("qualified success"). The number of medications before and after surgery will be considered.
Results:
Two males and 7 females with a mean age of 74.9 (range 65–87 years), underwent the OMNI TM surgery. The preoperative mean IOP was 18.40 ±6.02 mmHg. The postoperative IOP decreased to a mean of 12.35±3.37, 12.30±3.83, and 13.37±3.42 at 1 week, 1 month and 2 months, respectively. The number of antiglaucoma medications dropped from a mean of 3.15 preoperatively to 0.00, 0.00 and 0.25 at 1 week, 1 month and 2 months, respectively. Complications were: IOP-spikes (five patients), hyphema (six cases) and fibrin in the anterior chamber (one case) that resolved within one week.
Conclusions:
The OMNI TM is a promising approach for the treatment of open-angle glaucoma. The procedure achieves reduction of the intraocular pressure and number of glaucoma medications. It also demonstrates a good safety profile. The main advantages of the procedure are: a short surgical learning curve, performance speed, no implants or sutures, ability to be combined with cataract surgery, and no incisions in conjunctiva or sclera.
Financial Disclosure:
is employed by a for-profit company with an interest in the subject of the presentation